Bellevue Group AG
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Bellevue Group AG reported 148 stock positions worth $4.8 billion. Its top holding was Amgen (AMGN) at 6.5% of the portfolio, followed by Vertex Pharmaceuticals (VRTX, 6.0%) and Argenx SE - ADR (ARGX, 5.9%). Compared with Q1 2026, it opened 17 new positions, sold out of 24, added to 41 and reduced 66. The biggest buy was Amgen (AMGN, shares +188%) and the biggest sale Regeneron Pharmaceuticals (REGN, shares −44%).
- Most Recent 13F
- Q2 2026
- Location
- ZURICH, V8
- CIK
- 0001674546
- Portfolio Value
- $4.8B (Q2 2026)
- SEC Filing
- 0001104659-26-096739 ↗ filed Aug 14, 2026
Holdings Value
Holdings 148 stocks · $4.8B
| AMGN Amgen Inc. | 6.49% | 851,550 | $308.4M | Add +188.3% |
| VRTX Vertex Pharmaceuticals Inc. | 6.05% | 578,634 | $287.4M | Reduce -15.1% |
| ARGX Argenx SE - ADR | 5.88% | 301,000 | $279.3M | Reduce -3.8% |
| GILD Gilead Sciences Inc. | 5.74% | 2,158,772 | $272.7M | Add +84.5% |
| RVMD Revolution Medicines Inc. | 4.13% | 1,048,014 | $196.3M | Reduce -32.1% |
| ORKA Oruka Therapeutics Inc. | 3.32% | 1,657,190 | $157.7M | Add +226.9% |
| INSM Insmed Inc. | 3.13% | 1,393,418 | $148.6M | Add +13787.0% |
| SRRK Scholar Rock Holding Corp. | 2.83% | 2,449,547 | $134.7M | Reduce -31.7% |
| NUVL Nuvalent Inc. Class A | 2.74% | 1,053,268 | $130.1M | No change |
| VRDN Viridian Therapeutics Inc. | 2.60% | 6,731,909 | $123.7M | Add +0.1% |
| RLAY Relay Therapeutics Inc. | 2.44% | 6,185,970 | $115.7M | Reduce -20.6% |
| PCVX Vaxcyte Inc. | 2.41% | 1,971,935 | $114.6M | Add +65.6% |
| UTHR United Therapeutics Corp. | 2.15% | 188,515 | $102.1M | Add +8976.3% |
| ISRG Intuitive Surgical Inc. | 2.13% | 254,809 | $101.3M | Reduce -11.1% |
| REGN Regeneron Pharmaceuticals | 2.06% | 157,291 | $98.1M | Reduce -43.6% |
| CRNX Crinetics Pharmaceuticals Inc. | 2.06% | 2,620,000 | $98.0M | Reduce -20.1% |
| BBIO Bridgebio Pharma Inc. | 1.86% | 1,189,506 | $88.6M | Add +4587.3% |
| IMCR Immunocore Holdings PLC-ADR | 1.86% | 2,788,245 | $88.5M | Reduce -0.3% |
| ABT Abbott Laboratories | 1.81% | 947,115 | $85.9M | Reduce -17.8% |
| SYK Stryker Corp. | 1.78% | 268,461 | $84.5M | Add +23.6% |
| MDT Medtronic PLC | 1.64% | 994,233 | $77.8M | Add +3.9% |
| IONS Ionis Pharmaceuticals Inc. | 1.62% | 972,258 | $77.1M | Reduce -46.5% |
| ELVN Enliven Therapeutics Inc. | 1.59% | 1,490,000 | $75.6M | Reduce -35.8% |
| VERA Vera Therapeutics Inc. | 1.54% | 1,710,808 | $73.4M | Add +0.0% |
| JBIO Jade Biosciences Inc. | 1.43% | 3,057,996 | $67.9M | Reduce -12.7% |
| EW Edwards Lifesciences Corp. | 1.41% | 739,234 | $66.9M | Reduce -11.9% |
| RARE Ultragenyx Pharmaceutical Inc. | 1.39% | 1,982,775 | $66.2M | Reduce -16.7% |
| UNH Unitedhealth Group Inc. | 1.30% | 149,127 | $62.0M | Add +0.6% |
| DXCM Dexcom Inc. | 1.17% | 822,489 | $55.4M | Add +4.3% |
| CLDX Celldex Therapeutics Inc. | 0.94% | 1,200,000 | $44.7M | No change |
| AVLN Avalyn Pharma Inc. | 0.94% | 1,350,000 | $44.4M | New |
| DMRA Damora Therapeutics Inc. | 0.89% | 1,618,846 | $42.1M | Reduce -29.6% |
| IRON Disc Medicine Inc. | 0.86% | 560,000 | $41.0M | Add +21.9% |
| TMO Thermo Fisher Scientific Inc. | 0.84% | 79,816 | $40.0M | Add +23.9% |
| BSX Boston Scientific Corp. | 0.80% | 887,650 | $37.9M | Reduce -39.5% |
| LLY Eli Lilly & Co. | 0.75% | 29,882 | $35.8M | Reduce -11.9% |
| CGON CG Oncology Inc. | 0.74% | 493,596 | $35.1M | New |
| IDXX Idexx Laboratories Inc. | 0.68% | 61,780 | $32.5M | Reduce -30.7% |
| RMD Resmed Inc. | 0.61% | 148,195 | $28.9M | Reduce -7.0% |
| KRYS Krystal Biotech Inc. | 0.61% | 77,530 | $28.8M | Reduce -83.9% |
| GLUE Monte Rosa Therapeutics Inc. | 0.61% | 1,190,000 | $28.8M | Reduce -4.8% |
| DHR Danaher Corp. | 0.58% | 143,844 | $27.4M | Reduce -28.9% |
| JNJ Johnson & Johnson | 0.55% | 103,280 | $26.2M | Reduce -13.3% |
| SPTX Seaport Therapeutics Inc. | 0.50% | 1,100,000 | $23.9M | New |
| PVLA Palvella Therapeutics Inc. | 0.50% | 155,000 | $23.7M | New |
| ALGN Align Technology Inc. | 0.50% | 139,680 | $23.6M | No change |
| ANNX Annexon Inc. | 0.49% | 4,100,016 | $23.4M | Reduce -20.5% |
| HUM Humana Inc. | 0.49% | 58,398 | $23.2M | Reduce -9.5% |
| ELV Elevance Health Inc. | 0.46% | 56,449 | $21.8M | Add +7.5% |
| TNGX Tango Therapeutics Inc. | 0.46% | 694,182 | $21.7M | Reduce -71.1% |
| STE Steris PLC | 0.44% | 99,877 | $21.0M | Reduce 0.0% |
| SYRE Spyre Therapeutics Inc. | 0.43% | 229,931 | $20.4M | New |
| COAG Hemab Therapeutics Holdings | 0.43% | 550,000 | $20.2M | New |
| PODD Insulet Corp. | 0.41% | 127,498 | $19.4M | Reduce -22.1% |
| CI The Cigna Group | 0.39% | 66,500 | $18.3M | Reduce -32.3% |
| GKOS Glaukos Corp. | 0.38% | 128,667 | $18.0M | Reduce -11.7% |
| CVS CVS Health Corp. | 0.37% | 169,366 | $17.5M | Add +89.5% |
| BDX Becton Dickinson and Co. | 0.35% | 109,729 | $16.6M | Reduce -10.0% |
| GEHC GE Healthcare Technology | 0.34% | 252,744 | $16.2M | Reduce -39.4% |
| LIVN Livanova PLC | 0.34% | 195,621 | $16.1M | Add +5.1% |
| CNC Centene Corp. | 0.31% | 228,865 | $14.7M | Reduce -12.3% |
| MRK Merck & Co. Inc. | 0.31% | 113,061 | $14.5M | Reduce -45.3% |
| COO The Cooper Cos Inc. | 0.30% | 197,135 | $14.1M | Reduce -27.6% |
| PBLS Parabilis Medicines Inc. | 0.29% | 500,000 | $13.7M | New |
| TEVA Teva Pharmaceutical-SP ADR | 0.25% | 345,899 | $11.7M | Add +38.3% |
| GMED Globus Medical Inc. Class A | 0.24% | 146,108 | $11.5M | Reduce -40.9% |
| PRCT Procept Biorobotics Corp. | 0.24% | 502,286 | $11.3M | No change |
| ZBH Zimmer Biomet Holdings Inc. | 0.23% | 126,707 | $10.9M | Reduce -18.6% |
| VEEV Veeva Systems Inc. Class A | 0.22% | 59,347 | $10.5M | Add +5.0% |
| ABBV Abbvie Inc. | 0.21% | 40,476 | $10.2M | Reduce -56.7% |
| TXG 10X Genomics Inc. Class A | 0.21% | 261,470 | $10.0M | Reduce -20.6% |
| HCA HCA Healthcare Inc. | 0.19% | 23,750 | $9.3M | Reduce -37.1% |
| AURA Aura Biosciences Inc. | 0.17% | 1,166,667 | $8.3M | New |
| MCK McKesson Corp. | 0.15% | 9,625 | $7.3M | Reduce -56.9% |
| THC Tenet Healthcare Corp. | 0.15% | 38,868 | $7.3M | Add +1.6% |
| PTGX Protagonist Therapeutics Inc. | 0.14% | 55,682 | $6.8M | Add +285.4% |
| NTRA Natera Inc. | 0.14% | 24,806 | $6.7M | Reduce -21.7% |
| TMDX Transmedics Group Inc. | 0.14% | 101,139 | $6.7M | No change |
| MOH Molina Healthcare Inc. | 0.13% | 27,761 | $6.3M | New |
| ALKS Alkermes PLC | 0.13% | 120,243 | $6.3M | Add +1255.6% |
| RPRX Royalty Pharma PLC Class A | 0.13% | 112,311 | $6.3M | Add +193.3% |
| WAY Waystar Holding Corp. | 0.13% | 293,592 | $6.0M | Add +14.6% |
| PRVA Privia Health Group Inc. | 0.12% | 226,703 | $5.8M | No change |
| GMRS GMR Solutions Inc. Class A | 0.11% | 333,333 | $5.2M | New |
| NBIX Neurocrine Biosciences Inc. | 0.09% | 24,037 | $4.1M | Add +417.4% |
| OMDA Omada Health Inc. | 0.07% | 157,938 | $3.5M | No change |
| KMTS Kestra Medical Technologies | 0.07% | 129,215 | $3.3M | Add +11.8% |
| MDLN Medline Inc. Class A | 0.07% | 82,153 | $3.2M | Reduce -39.9% |
| ILMN Illumina Inc. | 0.07% | 18,134 | $3.2M | Reduce -10.3% |
| ONC Beone Medicines Ltd.-ADR | 0.06% | 10,474 | $3.0M | Add +174.8% |
| NAMS Newamsterdam Pharma Co. NV | 0.06% | 86,994 | $2.9M | Add +214.5% |
| MDGL Madrigal Pharmaceuticals Inc. | 0.05% | 4,675 | $2.5M | Add +53.8% |
| SPY SS SPDR S&P 500 ETF Trust-US | 0.04% | 2,700 | $2.0M | No change |
| BNTX Biontech SE-ADR | 0.04% | 21,229 | $2.0M | Add +1.8% |
| ADPT Adaptive Biotechnologies | 0.04% | 89,439 | $1.9M | Add +17.4% |
| CYTK Cytokinetics Inc. | 0.03% | 19,007 | $1.6M | Add +115.0% |
| ALMR Alamar Biosciences Inc. | 0.03% | 55,738 | $1.5M | New |
| PHR Phreesia Inc. | 0.03% | 140,495 | $1.4M | Add +7.3% |
| MOBI Mobia Medical Inc. | 0.03% | 100,000 | $1.3M | New |
| BLLN Billiontoone Inc. Class A | 0.03% | 10,554 | $1.3M | No change |
Portfolio Sells Q1 2026 → Q2 2026
| REGN Regeneron Pharmaceuticals | Reduce -43.6% | 2.06% | −3.06 |
| KRYS Krystal Biotech Inc. | Reduce -83.9% | 0.61% | −2.36 |
| ALNY Alnylam Pharmaceuticals Inc. | Reduce -99.5% | 0.01% | −1.84 |
| IONS Ionis Pharmaceuticals Inc. | Reduce -46.5% | 1.62% | −1.63 |
| BSX Boston Scientific Corp. | Reduce -39.5% | 0.80% | −1.39 |
| SRRK Scholar Rock Holding Corp. | Reduce -31.7% | 2.83% | −1.36 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -15.1% | 6.05% | −1.20 |
| EWTX Edgewise Therapeutics Inc. | Sold out | 0.00% | −1.15 |
| ISRG Intuitive Surgical Inc. | Reduce -11.1% | 2.13% | −1.01 |
| ABT Abbott Laboratories | Reduce -17.8% | 1.81% | −1.01 |
| CRNX Crinetics Pharmaceuticals Inc. | Reduce -20.1% | 2.06% | −0.77 |
| TNGX Tango Therapeutics Inc. | Reduce -71.1% | 0.46% | −0.74 |
| ELVN Enliven Therapeutics Inc. | Reduce -35.8% | 1.59% | −0.57 |
| DMRA Damora Therapeutics Inc. | Reduce -29.6% | 0.89% | −0.53 |
| IDXX Idexx Laboratories Inc. | Reduce -30.7% | 0.68% | −0.51 |
| PODD Insulet Corp. | Reduce -22.1% | 0.41% | −0.41 |
| GEHC GE Healthcare Technology | Reduce -39.4% | 0.34% | −0.37 |
| DHR Danaher Corp. | Reduce -28.9% | 0.58% | −0.34 |
| MCK McKesson Corp. | Reduce -56.9% | 0.15% | −0.31 |
| MRK Merck & Co. Inc. | Reduce -45.3% | 0.31% | −0.29 |
| ABBV Abbvie Inc. | Reduce -56.7% | 0.21% | −0.27 |
| GMED Globus Medical Inc. Class A | Reduce -40.9% | 0.24% | −0.26 |
| RMD Resmed Inc. | Reduce -7.0% | 0.61% | −0.24 |
| CI The Cigna Group | Reduce -32.3% | 0.39% | −0.24 |
| HCA HCA Healthcare Inc. | Reduce -37.1% | 0.19% | −0.23 |
| EW Edwards Lifesciences Corp. | Reduce -11.9% | 1.41% | −0.19 |
| ANNX Annexon Inc. | Reduce -20.5% | 0.49% | −0.19 |
| COO The Cooper Cos Inc. | Reduce -27.6% | 0.30% | −0.17 |
| IMCR Immunocore Holdings PLC-ADR | Reduce -0.3% | 1.86% | −0.14 |
| JNJ Johnson & Johnson | Reduce -13.3% | 0.55% | −0.14 |
| INSP Inspire Medical Systems Inc. | Sold out | 0.00% | −0.12 |
| BDX Becton Dickinson and Co. | Reduce -10.0% | 0.35% | −0.11 |
| ZBH Zimmer Biomet Holdings Inc. | Reduce -18.6% | 0.23% | −0.11 |
| PEN Penumbra Inc. | Sold out | 0.00% | −0.10 |
| RNA Atrium Therapeutics Inc. | Sold out | 0.00% | −0.08 |
| STE Steris PLC | Reduce 0.0% | 0.44% | −0.08 |
| MDLN Medline Inc. Class A | Reduce -39.9% | 0.07% | −0.08 |
| PFE Pfizer Inc. | Reduce -64.3% | 0.02% | −0.05 |
| MASI Masimo Corp. | Sold out | 0.00% | −0.04 |
| BMY Bristol-Myers Squibb Co. | Reduce -92.9% | 0.00% | −0.02 |
| EQNR Equinor ASA-Spon ADR | Sold out | 0.00% | −0.02 |
| XOM Exxon Mobil Corp. | Sold out | 0.00% | −0.02 |
| BP BP PLC-Spons ADR | Sold out | 0.00% | −0.02 |
| SHEL Shell PLC-ADR | Sold out | 0.00% | −0.02 |
| CSCO Cisco Systems Inc. | Sold out | 0.00% | −0.01 |
| BIIB Biogen Inc. | Reduce -90.8% | 0.00% | −0.01 |
| BABA Alibaba Group Holding-SP ADR | Sold out | 0.00% | −0.01 |
| MLYS Mineralys Therapeutics Inc. | Reduce -70.2% | 0.01% | −0.01 |
| PG The Procter & Gamble Co. | Sold out | 0.00% | −0.01 |
| MA Mastercard Inc. Class A | Sold out | 0.00% | −0.01 |
Portfolio Buys Q1 2026 → Q2 2026
| AMGN Amgen Inc. | Add +188.3% | 6.49% | +4.02 |
| INSM Insmed Inc. | Add +13787.0% | 3.13% | +3.09 |
| ORKA Oruka Therapeutics Inc. | Add +226.9% | 3.32% | +2.73 |
| UTHR United Therapeutics Corp. | Add +8976.3% | 2.15% | +2.12 |
| GILD Gilead Sciences Inc. | Add +84.5% | 5.74% | +1.86 |
| BBIO Bridgebio Pharma Inc. | Add +4587.3% | 1.86% | +1.82 |
| AVLN Avalyn Pharma Inc. | New | 0.94% | +0.94 |
| PCVX Vaxcyte Inc. | Add +65.6% | 2.41% | +0.77 |
| CGON CG Oncology Inc. | New | 0.74% | +0.74 |
| SPTX Seaport Therapeutics Inc. | New | 0.50% | +0.50 |
| PVLA Palvella Therapeutics Inc. | New | 0.50% | +0.50 |
| SYRE Spyre Therapeutics Inc. | New | 0.43% | +0.43 |
| COAG Hemab Therapeutics Holdings | New | 0.43% | +0.43 |
| UNH Unitedhealth Group Inc. | Add +0.6% | 1.30% | +0.35 |
| PBLS Parabilis Medicines Inc. | New | 0.29% | +0.29 |
| CVS CVS Health Corp. | Add +89.5% | 0.37% | +0.22 |
| AURA Aura Biosciences Inc. | New | 0.17% | +0.17 |
| IRON Disc Medicine Inc. | Add +21.9% | 0.86% | +0.16 |
| MOH Molina Healthcare Inc. | New | 0.13% | +0.13 |
| ALKS Alkermes PLC | Add +1255.6% | 0.13% | +0.13 |
| GMRS GMR Solutions Inc. Class A | New | 0.11% | +0.11 |
| PTGX Protagonist Therapeutics Inc. | Add +285.4% | 0.14% | +0.11 |
| ELV Elevance Health Inc. | Add +7.5% | 0.46% | +0.09 |
| RPRX Royalty Pharma PLC Class A | Add +193.3% | 0.13% | +0.09 |
| TMO Thermo Fisher Scientific Inc. | Add +23.9% | 0.84% | +0.09 |
| SYK Stryker Corp. | Add +23.6% | 1.78% | +0.08 |
| NBIX Neurocrine Biosciences Inc. | Add +417.4% | 0.09% | +0.07 |
| TEVA Teva Pharmaceutical-SP ADR | Add +38.3% | 0.25% | +0.07 |
| LIVN Livanova PLC | Add +5.1% | 0.34% | +0.06 |
| NAMS Newamsterdam Pharma Co. NV | Add +214.5% | 0.06% | +0.04 |
| ONC Beone Medicines Ltd.-ADR | Add +174.8% | 0.06% | +0.04 |
| ALMR Alamar Biosciences Inc. | New | 0.03% | +0.03 |
| MOBI Mobia Medical Inc. | New | 0.03% | +0.03 |
| CYTK Cytokinetics Inc. | Add +115.0% | 0.03% | +0.02 |
| ABVX Abivax SA-ADR | Add +510.4% | 0.02% | +0.02 |
| ADPT Adaptive Biotechnologies | Add +17.4% | 0.04% | +0.02 |
| MDGL Madrigal Pharmaceuticals Inc. | Add +53.8% | 0.05% | +0.01 |
| KMTS Kestra Medical Technologies | Add +11.8% | 0.07% | +0.01 |
| MANE Veradermics Inc. | New | 0.01% | +0.01 |
| DFTX Definium Therapeutics Inc. | New | 0.01% | +0.01 |
| GOOGL Alphabet Inc. Class A | Add +188.8% | 0.01% | +0.01 |
| VTRS Viatris Inc. | New | 0.01% | +0.01 |
| PHR Phreesia Inc. | Add +7.3% | 0.03% | +0.00 |
| COGT Cogent Biosciences Inc. | New | 0.00% | +0.00 |
| GRMN Garmin Ltd. | Add +49.6% | 0.01% | +0.00 |
| WAT Waters Corp. | New | 0.00% | +0.00 |
| AMZN Amazon.com Inc. | Add +18.6% | 0.01% | +0.00 |
| HALO Halozyme Therapeutics Inc. | Add +12.7% | 0.01% | +0.00 |
| CRSP Crispr Therapeutics AG | Add +16.0% | 0.01% | +0.00 |
| PRAX Praxis Precision Medicines I | Add +5.1% | 0.01% | −0.00 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 148 | $4.8B | AMGN, VRTX, ARGX, GILD, RVMD |
| Q1 2026 | 155 | $4.2B | VRTX, ARGX, REGN, SRRK, GILD |
| Q4 2025 | 176 | $5.3B | RVMD, ARGX, IONS, VRTX, NBIX |
| Q3 2025 | 148 | $4.8B | IONS, ARGX, RVMD, NBIX, ALNY |
| Q2 2025 | 142 | $4.5B | ARGX, IONS, NBIX, ALNY, ABT |
| Q1 2025 | 148 | $4.5B | ARGX, IONS, SYK, ISRG, ALNY |
| Q4 2024 | 160 | $5.2B | ARGX, IONS, NBIX, ISRG, ITCI |
| Q3 2024 | 162 | $6.2B | ARGX, IONS, VRTX, ISRG, ALNY |
| Q2 2024 | 166 | $6.2B | IONS, ARGX, VRTX, NBIX, ISRG |
| Q1 2024 | 169 | $6.6B | IONS, ARGX, NBIX, VRTX, ISRG |